Clinical Trials
55
Active:1
Completed:11
Trial Phases
4 Phases
Early Phase 1:1
Phase 2:8
Phase 4:7
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials
Not Applicable
20 (55.6%)Phase 2
8 (22.2%)Phase 4
7 (19.4%)Early Phase 1
1 (2.8%)Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - Older Adults in China）
Not yet recruiting
- Conditions
- Comprehensive Geriatric AssessmentChronic Disease ManagementOlder Adults (65 Years and Older)
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT07033871
Comparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and Safety
Not Applicable
Not yet recruiting
- Conditions
- CopdLung Cancer
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 26
- Registration Number
- NCT06929390
Prediction Model for Delayed Extubation of Tracheal Intubation in Patients With Maxillofacial Space Infection After Abscess Incision and Drainage Surgery
Not yet recruiting
- Conditions
- Oral Infection
- First Posted Date
- 2025-03-03
- Last Posted Date
- 2025-03-03
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06853808
Clinical Study of G Protein Biased Μ - Opioid Receptor Agonist Oliceridine for Optimizing Postoperative Analgesia Under General Anesthesia
- First Posted Date
- 2024-10-31
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT06668298
BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Esophageal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2024-09-09
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06588335
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
No news found